Category: Parkinson's Disease

UQ researchers are seeking volunteers diagnosed with Parkinson’s disease, and who have difficulty with their speech, to participate in a project. The School of Health and Rehabilitation Sciences project will examine lip, tongue, and jaw function in individuals with speech difficulties as a result of Parkinson’s disease.

Scientists suspect that iron accumulation plays a role in neurodegenerative processes such as Parkinson’s disease, but its distribution in neurons has never been observed because of the lack of techniques to do so. Until today.

A remarkable change takes place in the brains of tiny songbirds every year, and some day the mechanism controlling that change may help researchers develop treatments for age-related degenerative diseases of the brain such as Parkinson’s and dementia.

People with a certain gene mutation are more likely to get Parkinson’s disease before the age of 50 compared to those without the gene abnormality, according to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. For the study, researchers analyzed the genes of 278 people with Parkinson’s disease and 179 people without the disease.

Preliminary results of the pan-European PRODEST study in 1016 patients with Parkinson`s disease (PD) were presented at the 11th Congress of the European Federation of Neurological Societies (EFNS) in Brussels this week, revealing unique features of PD-related depression and its treatment.1 The study confirmed that depressive symptoms associated with PD are not only highly prevalent, but nearly half (44.

Preliminary results of the pan- European PRODEST study in 1016 patients with Parkinson’s disease (PD) were presented at the 11th Congress of the European Federation of Neurological Societies (EFNS) in Brussels this week, revealing unique features of PD-related depression and its treatment.1 The study confirmed that depressive symptoms associated with PD are not only highly prevalent, but nearly half (44.

Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson’s and Alzheimer’s diseases. The key is to weed out potentially destructive forms of iron that generate harmful free radicals while leaving benign forms of iron alone to carry out vital functions in the body.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The New York Academy of Sciences will co-host the inaugural PD Therapeutics Conference on Thursday, October 25, in New York City. This meeting is the first and only major scientific symposium exclusively focused on the development of innovative drugs to target Parkinson’s disease.

Predictive genetic testing for adult-onset diseases, including cancer, is generally discouraged until the age at which interventions are believed to be helpful. Yet, many children of BRCA mutation carriers learn of their parents’ genetic test results many years before preventive interventions are indicated.A new study in the Aug.

New evidence indicates that the loss of two types of brain cells–not just one as previously thought–may trigger the onset of symptoms associated with Parkinson’s disease.The evidence, based on mouse models, shows a link between the loss of both norepinephrine and dopamine neurons and the delayed onset of symptoms associated with Parkinson’s disease. It was originally thought that the loss of only dopamine neurons triggered symptoms.